1H11細(xì)胞 
	
		ATCC Number:	HB-10611?
	
	
		生長狀態(tài):	懸浮生長
	
	
		細(xì)胞形態(tài):	**樣
	
	
		**類型:	IgG1
	
	
		運輸方式:	凍存運輸
	
	
		數(shù)量:	大量
	
	
		是否是腫瘤細(xì)胞:	0
	
	
		1H11細(xì)胞物種來源:	小鼠
	
	
		Designations:	1H11
	
	
		Depositors:	 Washington Research Foundation
	
	
		Isotype:	IgG1
	
	
		Biosafety Level:	1
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	suspension
	
	
		Organism:	Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
	
	
		Morphology:	lymphoblast
	
	
		
	
	
		Source: 1H11細(xì)胞Cell Type: hybridoma: B lymphocyte;
	
	
		Cellular Products:	immunoglobulin; monoclonal antibody; against bone type 1 collagen amino terminal telopeptide
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Comments:	Animals were immunized with a conjugate of keyhole limpet hemocyanin (KLH) and a telopeptide having a 3-hydroxypyridinium crosslink derived from the amino terminal domain of bone type I collagen.
	
	
		Spleen cells were fused with mouse myeloma cells.
	
	
		The antibody can be used to detect and quantitate degradation products of bone type I collagen in body fluids.
	
	
		Propagation: 1H11細(xì)胞ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
	
	
		Temperature: 37.0°C
	
	
		Subculturing:	Medium Renewal: Every 2 to 3 days
	
	
		Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
	
	
		References:	22055: Eyre DR. 1H11細(xì)胞Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide. US Patent 5,300,434 dated Apr 5 1994